Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Lung Cancer

Free Subscription Articles published in Eur Respir J Retrieve available abstracts of 26 articles: HTML format Text format

Single Articles

October 2018
1. RICH AL, Baldwin DR, Beckett P, Berghmans T, et al
   ERS Statement on harmonised standards for lung cancer registration and lung cancer services in Europe.
   Eur Respir J. 2018 Oct 25. pii: 13993003.00610-2018.
   PubMed     Text format     Abstract available
   
   
   September 2018
2. MEYER G, Besse B, Doubre H, Charles-Nelson A, et al
   Antitumor Effect of Low Molecular Weight Heparin in Localised Lung Cancer A Phase III Clinical Trial.
   Eur Respir J. 2018 Sep 27. pii: 13993003.01220-2018.
   PubMed     Text format     Abstract available
   
   
   August 2018
3. VISSER S, Huisbrink J, van 't Veer NE, van Toor JJ, et al
   Renal impairment during pemetrexed maintenance in patients with advanced non-small-cell lung cancer: a cohort study.
   Eur Respir J. 2018 Aug 23. pii: 13993003.00884-2018.
   PubMed     Text format     Abstract available
   
   
   
4. VOLLMER I, Sanchez M, Rami-Porta R
   Lung cancer staging: imagine fewer images.
   Eur Respir J. 2018;52.
   PubMed     Text format    
   
   
   
5. TOURNOY KG, Van Meerbeeck JP
   Lung cancer staging: imagine fewer images.
   Eur Respir J. 2018;52.
   PubMed     Text format    
   
   
   June 2018
6. LOUBIERE S, Barlesi F, Missy P, Morin F, et al
   Cost-effectiveness of biomarker testing for treatment choices in advanced non-small cell lung carcinoma: impact of diagnostic strategies and their turnaround times.
   Eur Respir J. 2018;51.
   PubMed     Text format    
   
   
   
7. UGUEN A
   Cost-effectiveness of biomarker testing for treatment choices in advanced non-small cell lung carcinoma: impact of diagnostic strategies and their turnaround times.
   Eur Respir J. 2018;51.
   PubMed     Text format    
   
   
   May 2018
8. MIKESCH JH, Schwammbach D, Hartmann W, Schmidt LH, et al
   Reptin drives tumour progression and resistance to chemotherapy in non-small cell lung cancer.
   Eur Respir J. 2018 May 31. pii: 13993003.01637-2017.
   PubMed     Text format     Abstract available
   
   
   
9. SANDRI BJ, Kaplan A, Hodgson SW, Peterson M, et al
   Multi-Omic Molecular Profiling of Lung Cancer in Chronic Obstructive Pulmonary Disease.
   Eur Respir J. 2018 May 24. pii: 13993003.02665-2017.
   PubMed     Text format     Abstract available
   
   
   
10. SUN YQ, Brumpton BM, Bonilla C, Lewis SJ, et al
    Serum 25-hydroxyvitamin D levels and risk of lung cancer and histologic types: a Mendelian randomisation analysis of the HUNT study.
    Eur Respir J. 2018 May 10. pii: 13993003.00329-2018.
    PubMed     Text format     Abstract available
    
    
    
11. SCHEERENS C, Beernaert K, Pype P, Cohen J, et al
    Comparing the use and timing of palliative care services in COPD and lung cancer: a population-based survey.
    Eur Respir J. 2018;51.
    PubMed     Text format    
    
    
    April 2018
12. RAMI-PORTA R, Call S, Dooms C, Obiols C, et al
    Lung cancer staging: a concise update.
    Eur Respir J. 2018 Apr 26. pii: 13993003.00190-2018.
    PubMed     Text format     Abstract available
    
    
    March 2018
13. ZUGAZAGOITIA J, Biosca M, Olivera J, Eugenia Olmedo M, et al
    Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small-cell lung cancer.
    Eur Respir J. 2018 Mar 21. pii: 13993003.02431-2017.
    PubMed     Text format    
    
    
    
14. LOUBIERE S, Drezet A, Beau-Faller M, Moro-Sibilot D, et al
    Cost-effectiveness of KRAS, EGFR and ALK testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available
    
    
    December 2017
15. DECALUWE H, Dooms C, D'Journo XB, Call S, et al
    Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer: a prospective multicentre study.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available
    
    
    October 2017
16. SUN YQ, Chen Y, Langhammer A, Skorpen F, et al
    Passive smoking in relation to lung cancer incidence and histologic types in Norwegian adults: the HUNT study.
    Eur Respir J. 2017;50.
    PubMed     Text format    
    
    
    
17. PARIS C, Do P, Mastroianni B, Dixmier A, et al
    Association between lung cancer somatic mutations and occupational exposure in never-smokers.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available
    
    
    August 2017
18. TOMASINI P, Brosseau S, Mazieres J, Merlio JP, et al
    EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available
    
    
    
19. GLATZER M, Rittmeyer A, Muller J, Opitz I, et al
    Treatment of limited disease small cell lung cancer: the multidisciplinary team.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available
    
    
    July 2017
20. PLUVY J, Brosseau S, Naltet C, Opsomer MA, et al
    Lazarus syndrome in nonsmall cell lung cancer patients with poor performance status and major leukocytosis following nivolumab treatment.
    Eur Respir J. 2017;50.
    PubMed     Text format    
    
    
    May 2017
21. AAMLI GAGNAT A, Gjerdevik M, Gallefoss F, Coxson HO, et al
    Incidence of non-pulmonary cancer and lung cancer by amount of emphysema and airway wall thickness: a community-based cohort.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available
    
    
    April 2017
22. TIAN Q, Deng WJ, Li ZW
    Identification of a novel crizotinib-sensitive BCL11A-ALK gene fusion in a nonsmall cell lung cancer patient.
    Eur Respir J. 2017;49.
    PubMed     Text format    
    
    
    
23. KHIROYA H, Moore JS, Ahmad N, Kay J, et al
    IRP2 as a potential modulator of cell proliferation, apoptosis and prognosis in nonsmall cell lung cancer.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available
    
    
    
24. CALVAYRAC O, Pradines A, Pons E, Mazieres J, et al
    Molecular biomarkers for lung adenocarcinoma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available
    
    
    March 2017
25. LEDUC C, Antoni D, Charloux A, Falcoz PE, et al
    Comorbidities in the management of patients with lung cancer.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available
    
    
    
26. DE PERROT M, Dong Z, Bradbury P, Patsios D, et al
    Impact of tumour thickness on survival after radical radiation and surgery in malignant pleural mesothelioma.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: